Clinical trial
Rediscovery of Metformin for the Chronic Disabling Auto-inflammatory Disease Hidradenitis Suppurativa
NCT04649502 is registered in ClinicalTrials.gov with K.R. van Straalen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rediscovery of Metformin for the Chronic Disabling Auto-inflammatory Disease Hidradenitis Suppurativa
- Lead sponsor
- K.R. van Straalen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 25, 2021
- Completion date
- August 23, 2023
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.